2025-11-17T16:36:35-06:00 2024-12-31 561031342 WILLIAMS OVERMAN PIERCE LLP 328 E MARKET STREET SUITE 100 GREENSBORO NC 27401 990 2024-01-01 812849764 GLIOBLASTOMA FOUNDATION INC GLIO 9193091489 2451 CROASDAILE FARM PARKWAY 109 DURHAM NC 27705 MADAN KWATRA SECRETARY/TREASURER 9193091489 2025-11-17 1 1 MARYELLEN PRANCE CPA P01662078 3362751686 2025-11-17 X 2024 2025-03-06 01:10:19Z MADAN KWATRA 2451 CROASDAILE FARM PARKWAY 109 DURHAM NC 27705 2251075 0 X WWW.GLIOBLASTOMAFOUNDATION.ORG X 2016 NC TO IMPROVE TREATMENT OPTIONS FOR GLIOBLASTOMA PATIENTS BY FUNDING INNOVATIVE RESEARCH, EXPANDING ACCESS TO GENOMIC TESTING, SUPPORTING PATIENTS AND FAMILIES, AND RAISING NATIONAL AWARENESS OF THIS AGGRESSIVE BRAIN CANCER. 5 4 21 150 0 0 1691690 1964537 0 0 8094 2803 0 87878 1699784 2055218 245000 97474 0 0 516096 696475 0 0 13930 650396 1039715 1411492 1833664 288292 221554 2482026 3662658 0 496171 2482026 3166487 X THE GLIOBLASTOMA FOUNDATION IS DEDICATED TO FINDING A CURE FOR GLIOBLASTOMA BY FUNDING RESEARCH AND DRUG DEVELOPMENT, SUPPORTING PATIENTS AND FAMILIES, AND RAISING NATIONAL AWARENESS OF THIS DEVASTATING BRAIN CANCER. THROUGH THESE INTEGRATED PROGRAMS, THE FOUNDATION ACCELERATES SCIENTIFIC DISCOVERY, EMPOWERS PATIENTS WITH INFORMATION AND RESOURCES, AND EDUCATES THE PUBLIC ABOUT THE URGENT NEED FOR BETTER TREATMENTS AND IMPROVED OUTCOMES. 1 0 527251 97474 RESEARCH AND DRUG DEVELOPMENT:IN 2024, THE GLIOBLASTOMA FOUNDATION ADVANCED ITS RESEARCH MISSION BY ACQUIRING LISAVANBULIN, A PROMISING TARGETED THERAPY FROM BASILEA PHARMACEUTICA, FOR FURTHER CLINICAL DEVELOPMENT IN GLIOBLASTOMA. THIS ACQUISITION MARKED A CRITICAL STEP TOWARD BRINGING PATIENTS NEW, MORE EFFECTIVE TREATMENTS. THE FOUNDATION ALSO SUPPORTED INVESTIGATOR-INITIATED RESEARCH ON MOLECULAR CHARACTERIZATION AND FUNCTIONAL PRECISION ONCOLOGY. ADDITIONALLY, THE FOUNDATION ESTABLISHED GLIOLAB, A CLIA-REGISTERED GENOMIC LABORATORY THAT WILL PROVIDE STATE-OF-THE-ART TESTING TO ACCELERATE DISCOVERY OF TARGETED THERAPIES BASED ON EACH TUMOR'S GENOMIC AND EPIGENOMIC PROFILE. 527251 PATIENT SUPPORT AND EDUCATION:THROUGHOUT 2024, THE FOUNDATION PROVIDED SUPPORT SERVICES FOR GLIOBLASTOMA PATIENTS AND CAREGIVERS NATIONWIDE, INCLUDING PERSONALIZED CLINICAL-TRIAL MATCHING, PROFESSIONALLY LED VIRTUAL SUPPORT GROUPS, AND EDUCATIONAL RESOURCES ON TREATMENT OPTIONS AND EMERGING RESEARCH. THESE PROGRAMS EMPOWERED PATIENTS TO MAKE INFORMED CARE DECISIONS AND FOSTERED A SENSE OF COMMUNITY AMONG FAMILIES AFFECTED BY THIS RARE DISEASE. HUNDREDS OF PATIENTS AND CAREGIVERS BENEFITED FROM THESE FREE SERVICES DURING THE YEAR. 527250 PUBLIC AWARENESS AND ADVOCACY:THE FOUNDATION LED NATIONWIDE EFFORTS TO RAISE AWARENESS AND ADVOCACY FOR THOSE AFFECTED BY GLIOBLASTOMA. IN 2024, IT ORGANIZED GLIOBLASTOMA AWARENESS DAY AND CONTINUED THE VOICES OF GLIOBLASTOMA PODCAST WHILE PLANNING TO EXPAND THE SERIES IN FUTURE YEARS TO FEATURE ADDITIONAL PATIENT, CAREGIVER, AND SCIENTIST PERSPECTIVES. THE FOUNDATION ALSO PARTNERED WITH EVENTS SUCH AS THE LOS ANGELES MARATHON TO INCREASE PUBLIC UNDERSTANDING AND SUPPORT FOR RESEARCH. THESE INITIATIVES EDUCATED THOUSANDS AND INSPIRED HOPE WITHIN THE GLIOBLASTOMA COMMUNITY. 1581752 1 1 0 0 0 0 0 0 0 0 1 1 0 1 1 0 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 21 1 0 0 0 0 0 0 0 0 0 0 0 0 X 5 4 1 0 0 0 0 0 0 1 1 1 0 1 1 1 1 1 1 1 0 0 X MADAN KWATRA 9194021775 2451 CROASDAILE FARM PARKWAY 109 DURHAM NC 27705 NEELAM KWATRA PRESIDENT 20.00 X X 0 0 0 MADAN KWATRA TREASURER/SECRETARY 4.00 X X 0 0 0 GITA KWATRA CEO 40.00 X X 291500 0 51548 CAMERON WEST BOARD MEMBER 1.00 X 0 0 0 BRIAN AUSTIN BOARD MEMBER 1.00 X 0 0 0 291500 0 51548 1 0 1 0 FINNEGAN HENDERSON FARABOW GARRETT 901 NEW YORK AVENUE NW WASHINGTON DC 20001 LEGAL SERVICES 109886 1 1964537 1964537 22886 22886 121652 141735 -20083 -20083 -20083 142000 54122 87878 87878 2055218 0 0 90681 97474 97474 343048 325896 10291 6861 313484 297809 9405 6270 39943 37946 1198 799 109886 109886 33284 33284 328033 328033 22945 22945 15734 15734 69379 69379 21601 21601 3328 3328 56674 54407 2267 3874 3874 FACILITIES AND EQUIPMEN 211652 211652 CONTRACT SERVICES 77821 77821 RESEARCH EXPENSE 36798 36798 MISCELLANEOUS 14695 14695 34011 34011 1833664 1581752 237982 13930 1025929 611752 18250 10920 156360 8947 6267 147413 1431580 2246251 0 259450 0 386872 2482026 3662658 0 142529 0 353642 0 496171 X 2482026 3166487 2482026 3166487 2482026 3662658 221554 511923 -49016 0 X X 0 1 X 1 0 X 842093 1302093 1513382 1691690 1964537 7313795 842093 1302093 1513382 1691690 1964537 7313795 52550 7261245 4227 9185 14333 8094 22885 58724 7372519 0.98490 0.99390 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 156360 8947 147413 147413 ETRADE 2246251 F 2246251 DEPOSITS 34702 RIGHT OF USE ASSET 352070 OTHER 100 386872 SHORT TERM LEASE LIABILITY 199346 LONG TERM LEASE LIABILITY 154296 353642 2621263 511923 54122 566045 2055218 0 2055218 1887786 54122 54122 1833664 0 1833664 PART XI, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES REPORTED ON PART VIII LINE 8B 54,122. PART XII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES REPORTED ON PART VIII LINE 8B 54,122. X BRUCE LIETZKE GOLF EVENT 142000 142000 6417 19968 27737 142000 142000 6417 19968 27737 54122 87878 1 TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 615 W 131ST STREET 8741 NEW YORK NY 10027 911859360 50000 0 GLIOBLASTOMA RESEARCH CONGRESS OF NEUROLOGICAL SURGEONS 10 NORTH MARTINGALE ROAD SUITE 190 SCHAUMBURG IL 60173 900917138 10000 0 GLIOBLASTOMA RESEARCH NORTHWESTERN UNIVERSITY 633 CLARK ST EVANSTON IL 60208 362167817 11566 0 GLIOBLASTOMA RESEARCH JOHN HOPKINS UNIVERSITY 3400 NORTH CHARLES ST BALTIMORE MD 21218 520595110 17685 0 GLIOBLASTOMA RESEARCH 4 X 0 0 0 0 0 0 0 0 0 GITA KWATRA CEO 291500 0 0 0 0 0 23000 0 28548 0 343048 0 0 0 FORM 990, PART III, LINE 2 FIRST, THE FOUNDATION ACQUIRED LISAVANBULIN, A PROMISING TARGETED THERAPY FROM BASILEA PHARMACEUTICA, MARKING A SIGNIFICANT EXPANSION OF ITS RESEARCH AND DRUG-DEVELOPMENT EFFORTS AIMED AT IMPROVING TREATMENT OPTIONS FOR GLIOBLASTOMA PATIENTS. SECOND, THE FOUNDATION INITIATED DEVELOPMENT OF GLIOLAB, A CLIA-REGISTERED GENOMIC LABORATORY THAT WILL PROVIDE STATE-OF-THE-ART MOLECULAR AND GENOMIC TESTING TO ENSURE THAT EVERY GLIOBLASTOMA PATIENT HAS ACCESS TO PRECISION DIAGNOSTICS. BOTH INITIATIVES REPRESENT MAJOR MILESTONES IN THE FOUNDATION'S MISSION TO TRANSFORM GLIOBLASTOMA FROM TERMINAL TO TREATABLE THROUGH PRECISION MEDICINE AND TRANSLATIONAL RESEARCH. FORM 990, PART VI, SECTION A, LINE 2 THREE BOARD MEMBERS, WHO ARE THE ORGANIZATION'S FOUNDERS, ARE FAMILY MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS AVAILABLE TO THE ORGANIZATION'S ENTIRE GOVERNING BODY AND BOARD MEMBERS. FORM 990 IS REVIEWED BY THE ORGANIZATION'S PRESIDENT AND TREASURER BEFORE IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C EMPLOYEES AND DIRECTORS ARE REQUIRED TO DISCLOSE CONFLICT OF INTERESTS WHEN THEY ARISE AND ARE REQUIRED TO FILE AN ANNUAL DISCLOSURE FORM. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION IS IN ACCORDANCE WITH NATIONAL STANDARDS FOR OTHER HEALTHCARE NONPROFITS. FORM 990, PART VI, SECTION C, LINE 18 THE FOUNDATION'S FORM 990 IS PUBLICLY AVAILABLE THROUGH THE IRS WEBSITE, PROPUBLICA NONPROFIT EXPLORER, AND OTHER NONPROFIT DATABASES, ENSURING FULL TRANSPARENCY FOR DONORS AND THE PUBLIC. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S CONFLICT OF INTEREST POLICY IS AVAILABLE UPON REQUEST. FORM 990, PART VII CONTACT ADDRESSES FOR OFFICERS, DIRECTORS, ETC CAMERON WEST - 517 E 30TH AVE, HUTCHINSON, KS 67502. BRIAN AUSTIN - 900 FIELD CLUB RD, PITTSBURGH, PA 15238. FORM 990, PART XII, LINE 2C: THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR